HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anesthetic management of an infant with pulmonary atresia and ventricular septal defect accompanied by excess pulmonary blood flow for systemic-pulmonary shunt operation].

Abstract
A 6-month-old infant had pulmonary atresia with ventricular septal defect (PA + VSD) accompanied by excess pulmonary artery flow via major aortopulmonary collateral artery, underwent aortopulmonary shunt with artificial graft under midazolam-fentanyl anesthesia. After the administration of protamine, arterial oxygen saturation gradually decreased. We suspected that hypotension and decrease in cardiac output induced by protamine caused the decrease in pulmonary blood flow via central shunt. It is suggested that pulmonary blood flow should be maintained by using an inotropic agent and a selective pulmonary arterial dilator such as prostaglandin E1 in a patient with PA + VSD after the institution of aorto-pulmonary shunt, because the patient with excess pulmonary flow has been reported to have high pulmonary resistance due to pulmonary abnormalities such as stenosis and thrombosis.
AuthorsT Ataka, S Fukuda, H Kinoshita, S Kurokawa, Y Kitahara, K Shimoji, H Watanabe, S Sato
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 48 Issue 4 Pg. 372-6 (Apr 1999) ISSN: 0021-4892 [Print] Japan
PMID10339934 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Anesthesia, Intravenous
  • Blood Vessel Prosthesis Implantation
  • Collateral Circulation
  • Female
  • Heart Septal Defects, Ventricular (complications, surgery)
  • Humans
  • Infant
  • Intraoperative Care
  • Pulmonary Atresia (complications, physiopathology, surgery)
  • Pulmonary Circulation
  • Vascular Surgical Procedures

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: